Information Provided By: 
Fly News Breaks for August 29, 2016
MDRX
Aug 29, 2016 | 07:28 EDT
SunTrust analyst Sandy Draper says that Allscripts' fundamentals appear to be improving, as its organic bookings growth in 2H16 came in at about 15%, up from approximately 8.5% in 2H15. However, the analyst says that, "evidence of stabilized client retention, growth in recurring revenue and better backlog pull-through is needed to catalyze upside in the stock." He keeps a $15 price target and Buy rating on the shares.
News For MDRX From the Last 2 Days
There are no results for your query MDRX
